Alternative form of artemether-lumefantrine for infants

The Lancet

Volumn 372, Issue 9652, 2008, Pages 1786-1787

  Teklehaimanot, Awash ^a   Teklehaimanot, Hailay Desta ^b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Center for National Health Development in Ethiopia   (Ethiopia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; FLAVORING AGENT;

AFRICA; ARTICLE; BITTER TASTE; DISPERSIBLE TABLET; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG FORMULATION; DRUG HALF LIFE; DRUG RESISTANCE; DRUG SAFETY; FOLLOW UP; HUMAN; MALARIA; MORBIDITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; TREATMENT RESPONSE; VOMITING;

EID: 56349110336     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61493-2     Document Type: Note

References (10)

1. Abdulla S., Sagara I., Borrmann S., et al. Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial. Lancet (2008) 10.1016/S0140-6736(08)61492-0 published online Oct 15.
2. White N.J. The assessment of antimalarial drug efficacy. Trends Parasitol 18 (2002) 458-464
3. Makanga M., Premji Z., Falade C., et al. Efficacy and safety of the six-dose regimen of artemether-lumefantrine in pediatrics with uncomplicated Plasmodium falciparum malaria: a pooled analysis of individual patient data. Am J Trop Med Hyg 74 (2006) 991-998
4. Mueller E.A., van Vugt M., Kirch W., Andriano K., Hunt P., and de Palacios P.I. Efficacy and safety of the six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in adolescents and adults: a pooled analysis of individual patient data from randomized clinical trials. Acta Tropica 100 (2006) 41-53
5. Omari A., Gamble C., and Garner P. Artemether-lumefantrine (six-dose regimen) for treating uncomplicated falciparum malaria. Cochrane Database Syst Rev 4 (2005) CD005564.
6. WHO. Scaling up home-based management of malaria: from research to implementation (2004). http://www.who.int/tdr/publications/publications/pdf/home_2004.pdf (accessed Aug 27, 2008).
7. Barnes K.I., Watkins W.M., and White N.J. Antimalarial dosing regimens and drug resistance. Trends Parasitol 24 (2008) 127-134
8. Snow R.W., Guerra C.A., Noor A.M., Myint H.Y., and Hay S.I. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434 (2005) 214-217
9. Yeung S., and White N.J. How do patients use antimalarial drugs? A review of the evidence. Trop Med Int Health 10 (2005) 121-138
10. Ramharter M., Kurth F.M., Belard S., et al. Pharmacokinetics of two paediatric artesunate mefloquine drug formulations in the treatment of uncomplicated falciparum malaria in Gabon. J Antimicrob Chemother 60 (2007) 1091-1096